A Phase 3b, Multi-Center, Randomized, Open-Label, Pragmatic Study of Glecaprevir/Pibrentasvir (G/P) +/- Ribavirin for GT1 Subjects with Chronic Hepatitis C Previously Treated with an NS5A Inhibitor + Sofosbuvir Therapy
Clinical Trial Grant
Administered By
Medicine, Gastroenterology
Awarded By
University of Florida
Start Date
March 20, 2017
End Date
April 30, 2019
Administered By
Medicine, Gastroenterology
Awarded By
University of Florida
Start Date
March 20, 2017
End Date
April 30, 2019